Descending Control Mechanisms

The Senses: A Comprehensive Reference

Volumn 5, Issue , 2008, Pages 723-762

  Ren, K ^a   Dubner, R ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Analgesia; Bulbospinal pathways; Descending facilitation; Descending inhibition; Endogenous opioids; Hyperalgesia; Inflammation; LC SC; Nerve injury; Noradrenergic; PAG; Pain; Persistent pain; RVM; Serotonergic

Indexed keywords

EID: 84882500317     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370880-9.00192-4     Document Type: Chapter

References (432)

1. Aarnisalo A.A., Panula P. Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: a Phaseolus vulgaris leucoagglutinin study. Neuroscience 1995, 65:175-192.
2. Abbott F.V., Hong Y., Franklin K.B. The effect of lesions of the dorsolateral funiculus on formalin pain and morphine analgesia: a dose-response analysis. Pain 1996, 65:17-23.
3. Ackley M.A., Hurley R.W., Virnich D.E., Hammond D.L. A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain 2001, 91:377-388.
4. Ahmadi S., Muth-Selbach U., Lauterbach A., Lipfert P., Neuhuber W.L., Zeilhofer H.U. Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science 2003, 300:2094-2097.
5. Aicher S.A., Saravay R.H., Cravo S., Jeske I., Morrison S.F., Reis D.J., Milner T.A. Monosynaptic projections from the nucleus tractus solitarii to C1 adrenergic neurons in the rostral ventrolateral medulla: comparison with input from the caudal ventrolateral medulla. J. Comp. Neurol. 1996, 373:62-75.
6. Aimone L.D., Gebhart G.F. Stimulation-produced spinal inhibition from the midbrain in the rat is mediated by an excitatory amino acid neurotransmitter in the medial medulla. J. Neurosci. 1986, 6:1803-1813.
7. Aimone L.D., Bauer C.A., Gebhart G.F. Brain-stem relays mediating stimulation-produced antinociception from the lateral hypothalamus in the rat. J. Neurosci. 1988, 8:2652-2663.
8. Akil H., Mayer D.J., Liebeskind J.C. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 1976, 191:961-962.
9. Antal M., Petko M., Polgar E., Heizmann C.W., Storm-Mathisen J. Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla. Neuroscience 1996, 73:509-518.
10. Azami J., Green D.L., Roberts M.H., Monhemius R. The behavioural importance of dynamically activated descending inhibition from the nucleus reticularis gigantocellularis pars alpha. Pain 2001, 92:53-62.
11. Azkue J.J., Mateos J.M., Elezgarai I., Benitez R., Lazaro E., Streit P., Grandes P. Glutamate-like immunoreactivity in ascending spinofugal afferents to the rat periaqueductal grey. Brain Res. 1998, 790:74-81.
12. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci. 1994, 17:379-389.
13. Barbaresi P., Gazzanelli G., Malatesta M. Glutamate-positive neurons and terminals in the cat periaqueductal gray matter (PAG): a light and electron microscopic immunocytochemical study. J. Comp. Neurol. 1997, 383:381-396.
14. Basbaum A.I., Fields H.L. The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: further studies on the anatomy of pain modulation. J. Comp. Neurol. 1979, 187:513-531.
15. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 1984, 7:309-338.
16. Basbaum A.I., Marley N.J., O'Keefe J., Clanton C.H. Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions. Pain 1977, 3:43-56.
17. Battaglia G., Rustioni A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J. Comp. Neurol. 1988, 277:302-312.
18. Bederson J.B., Fields H.L., Barbaro N.M. Hyperalgesia following naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla. Somatosens. Motor Res. 1990, 7:185-203.
19. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol. 1995, 46:575-605.
20. Behbehani M.M., Fields H.L. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced analgesia. Brain Res. 1979, 170:85-93.
21. Behbehani M.M., Pomeroy S.L. Effect of morphine injected in periaqueductal gray on the activity of single units in nucleus raphe magnus of the rat. Brain Res. 1978, 149:266-269.
22. Beitz A.J. The nuclei of origin of brain stem enkephalin and substance P projections to the rodent nucleus raphe magnus. Neuroscience 1982, 7:2753-2768.
23. Beitz A.J. The organization of afferent projections to the midbrain periaqueductal gray of the rat. Neuroscience 1982, 7:133-159.
24. Beitz A.J. The sites of origin brain stem neurotensin and serotonin projections to the rodent nucleus raphe magnus. J. Neurosci. 1982, 2:829-842.
25. Beitz A.J., Shepard R.D., Wells W.E. The periaqueductal gray-raphe magnus projection contains somatostatin, neurotensin and serotonin but not cholecystokinin. Brain Res. 1983, 261:132-137.
26. Bellavance L.L., Beitz A.J. Altered c-fos expression in the parabrachial nucleus in a rodent model of CFA-induced peripheral inflammation. J. Comp. Neurol. 1996, 366:431-447.
27. Bellchambers C.E., Chieng B., Keay K.A., Christie M.J. Swim-stress but not opioid withdrawal increases expression of c-fos immunoreactivity in rat periaqueductal gray neurons which project to the rostral ventromedial medulla. Neuroscience 1998, 83:517-524.
28. Benedetti F., Amanzio M. The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin. Prog. Neurobiol. 1997, 52:109-125.
29. Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J. Neurosci. 2003, 23:4315-4323.
30. Bernard J.F., Alden M., Besson J.-M. The organization of the efferent projections from the pontine parabrachial area to the amygdaloid complex: a Phaseolus vulgaris leucoagglutinin (PHA-L) study in the rat. J. Comp. Neurol. 1993, 329:201-229.
31. Berrino L., Oliva P., Rossi F., Palazzo E., Nobili B., Maione S. Interaction between metabotropic and NMDA glutamate receptors in the periaqueductal grey pain modulatory system. Naunyn Schmiedebergs Arch. Pharmacol. 2001, 364:437-443.
32. Besson J.M., Guilbaud G., Le Bars D. Descending inhibitory influences exerted by the brain stem upon the activities of dorsal horn lamina V cells induced by intra-arterial injection of bradykinin into the limbs. J. Physiol. 248725-739. 1975.
33. Bester H., Besson J.-M., Bernard J.F. Organization of efferent projections from the parabrachial area to the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J. Comp. Neurol 1997, 383:245-281.
34. Bester H., Chapman V., Besson J.-M., Bernard J.F. Physiological properties of the lamina I spinoparabrachial neurons in the rat. J. Neurophysiol. 2000, 83:2239-2259.
35. Bie B., Pan Z.Z. Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors. J. Neurosci. 2003, 23:7262-7268.
36. Bie B., Pan Z.Z. Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats. Mol. Pain. 2005, 1:7.
37. Bie B., Fields H.L., Williams J.T., Pan Z.Z. Roles of alpha1- and alpha2-adrenoceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia. J. Neurosci. 2003, 23:7950-7957.
38. Bitner R.S., Nikkel A.L., Curzon P., Arneric S.P., Bannon A.W., Decker M.W. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons. J. Neurosci. 1998, 18:5426-5432.
39. Bohn L.M., Xu F., Gainetdinov R.R., Caron M.G. Potentiated opioid analgesia in norepinephrine transporter knock-out mice. J. Neurosci. 2000, 20:9040-9045.
40. Bouhassira D., Chitour D., Villanueva L., Le Bars D. Morphine and diffuse noxious inhibitory controls in the rat: effects of lesions of the rostral ventromedial medulla. Eur. J. Pharmacol. 1993, 232:207-215.
41. Bouhassira D., Villanueva L., Bing Z., Le Bars D. Involvement of the subnucleus reticularis dorsalis in diffuse noxious inhibitory controls in the rat. Brain Res. 1992, 595:353-357.
42. Bowker R.M., Abbott L.C., Dilts R.P. Peptidergic neurons in the nucleus raphe magnus and the nucleus gigantocellularis: their distributions, interrelationships, and projections to the spinal cord. Prog. Brain Res. 1988, 77:95-127.
43. Bowker R.M., Westlund K.N., Sullivan M.C., Wilber J.F., Coulter J.D. Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: a multiple transmitter complex. Brain Res. 1983, 288:33-48.
44. Buhler A.V., Proudfit H.K., Gebhart G.F. Separate populations of neurons in the rostral ventromedial medulla project to the spinal cord and to the dorsolateral pons in the rat. Brain Res. 2004, 1016:12-19.
45. Buhler A.V., Choi J., Proudfit H.K., Gebhart G.F. Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive. Pain 2005, 114:285-294.
46. Burgess S.E., Gardell L.R., Ossipov M.H., Malan T.P., Vanderah T.W., Lai J., Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 2002, 22:5129-5136.
47. Buritova J., Besson J.M., Bernard J.F. Involvement of the spinoparabrachial pathway in inflammatory nociceptive processes: a c-Fos protein study in the awake rat. J. Comp. Neurol. 1998, 397:10-28.
48. Burnett A., Gebhart G.F. Characterization of descending modulation of nociception from the A5 cell group. Brain Res. 1991, 546:271-281.
49. Camarata P.J., Yaksh T.L. Characterization of the spinal adrenergic receptors mediating the spinal effects produced by the microinjection of morphine into the periaqueductal gray. Brain Res. 1985, 336:133-142.
50. Cameron A.A., Khan I.A., Westlund K.N., Willis W.D. The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. II. Descending projections. J. Comp. Neurol. 1995, 351:585-601.
51. Cameron A.A., Khan I.A., Westlund K.N., Cliffer K.D., Willis W.D. The efferent projections of the periaqueductal gray in the rat: a Phaseolus vulgaris-leucoagglutinin study. I. Ascending projections. J. Comp. Neurol. 1995, 351:568-584.
52. Calejesan A.A., Kim S.J., Zhuo M. Descending facilitatory modulation of a behavioral nociceptive response by stimulation in the adult rat anterior cingulate cortex. Eur. J. Pain 2000, 4:83-96.
53. Cannon K.E., Nalwalk J.W., Stadel R., Ge P., Lawson D., Silos-Santiago I., Hough L.B. Activation of spinal histamine H3 receptors inhibits mechanical nociception. Eur. J. Pharmacol. 2003 2003, 470:139-147.
54. Carlson J.D., Iacono R.P., Maeda G. Nociceptive excited and inhibited neurons within the pedunculopontine tegmental nucleus and cuneiform nucleus. Brain Res. 2004, 1013:182-187.
55. Carstens E., Klumpp D., Zimmermann M. Differential inhibitory effects of medial and lateral midbrain stimulation on spinal neuronal discharges to noxious skin heating in the cat. J Neurophysiol. 1980, 43:332-342.
56. Cejas P.J., Martinez M., Karmally S., McKillop M., McKillop J., Plunkett J.A., Oudega M., Eaton M.J. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain 2000, 86:195-210.
57. Cervero F., Laird J.M. Mechanisms of touch-evoked pain (allodynia): a new model. Pain 1996, 68:13-23.
58. Cervero F., Wolstencroft J.H. A positive feedback loop between spinal cord nociceptive pathways and antinociceptive areas of the cat′s brain stem. Pain 1984, 20:125-138.
59. Cervero F., Iggo A., Ogawa H. Nociceptor-driven dorsal horn neurones in the lumbar spinal cord of the cat. Pain 1976, 2:5-24.
60. Cervero F., Molony V., Iggo A. Supraspinal linkage of substantia gelatinosa neurones: effects of descending impulses. Brain Res. 1979, 175:351-355.
61. Chen H., Weber A.J. Brain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult rats. Brain Res. 2004, 1011:99-106.
62. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 1993, 44:8-12.
63. Chiang C.Y., Hu J.W., Sessle B.J. Parabrachial area and nucleus raphe magnus-induced modulation of nociceptive and nonnociceptive trigeminal subnucleus caudalis neurons activated by cutaneous or deep inputs. J. Neurophysiol. 1994, 71:2430-2445.
64. Cho H.J., Basbaum A.I. GABAergic circuitry in the rostral ventral medulla of the rat and its relationship to descending antinociceptive controls. J. Comp. Neurol. 1991, 303:316-328.
65. Clark F.M., Proudfit H.K. The projection of locus coeruleus neurons to the spinal cord in the rat determined by anterograde tracing combined with immunocytochemistry. Brain Res. 1991, 538:231-245.
66. Clark F.M., Proudfit H.K. The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res. 1993, 616:200-210.
67. Collins J.G., Ren K. WDR response profiles of spinal dorsal horn neurons may be unmasked by barbiturate anesthesia. Pain 1987, 28:369-378.
68. Commons K.G., Valentino R.J. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J. Comp. Neurol. 2002, 447:82-97.
69. Cordero-Erausquin M., Changeux J.P. Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:2803-2807.
70. Cordero-Erausquin M., Pons S., Faure P., Changeux J.P. Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord. Pain 2004, 109:308-318.
71. Cravatt B.F., Lichtman A.H. The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol. 2004, 61:149-160.
72. Cronin J.N., Bradbury E.J., Lidierth M. Laminar distribution of GABAA- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumbar spinal cord: effects of picrotoxin and strychnine on expression of Fos-like immunoreactivity. Pain 2004, 112:156-163.
73. Cucchiaro G., Chaijale N., Commons K.G. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine. J. Pharmacol. Exp. Ther. 2005, 313:389-394.
74. Cui J.G., O'Connor W.T., Ungerstedt U., Linderoth B., Meyerson B.A. Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism. Pain 1997, 73:87-95.
75. Cui M., Feng Y., McAdoo D.J., Willis W.D. Periaqueductal gray stimulation-induced inhibition of nociceptive dorsal horn neurons in rats is associated with the release of norepinephrine, serotonin, and amino acids. J. Pharmacol. Exp. Ther. 1999, 289:868-876.
76. Dahlström A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 1964, 62(Suppl 232):1-55.
77. Danzebrink R.M., Gebhart G.F. Intrathecal coadministration of clonidine with serotonin receptor agonists produces supra-additive visceral antinociception in the rat. Brain Res. 1991, 555:35-42.
78. Danziger N., Weil-Fugazza J., Le Bars D., Bouhassira D. Alteration of descending modulation of nociception during the course of monoarthritis in the rat. J. Neurosci. 1999, 19:2394-2400.
79. Danziger N., Weil-Fugazza J., Le Bars D., Bouhassira D. Stage-dependent changes in the modulation of spinal nociceptive neuronal activity during the course of inflammation. Eur J Neurosci. 2001, 13:230-240.
80. de Novellis V., Mariani L., Palazzo E., Vita D., Marabese I., Scafuro M., Rossi F., Maione S. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 2005, 134:269-281.
81. Depaulis A., Morgan M.M., Liebeskind J.C. GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain Res. 1987, 436:223-228.
82. Dickenson A.H., Oliveras J.L., Besson J.M. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res. 1979, 170:95-111.
83. Dickhaus H., Pauser G., Zimmermann M. Tonic descending inhibition affects intensity coding of nociceptive responses of spinal dorsal horn neurones in the cat. Pain 1985, 23:145-158.
84. Dostrovsky J.O., Shah Y., Gray B.G. Descending inhibitory influences from periaqueductal gray, nucleus raphe magnus, and adjacent reticular formation. II. Effects on medullary dorsal horn nociceptive and nonnociceptive neurons. J. Neurophysiol. 1983, 49:948-960.
85. Dubner R., Bennett G.J. Spinal and trigeminal mechanisms of nociception. Annu. Rev. Neurosci. 1983, 6:381-418.
86. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 1992, 15:96-103.
87. Dubuisson D., Wall P.D. Medullary raphe influences on units in laminae 1 and 2 of cat spinal cord. J. Physiol. (Lond) 1979, 300:33P.
88. Dubuisson D., Wall P.D. Descending influences on receptive fields and activity of single units recorded in laminae 1,2 and 3 of cat spinal cord. Brain Res. 1980, 199:283-298.
89. Duggan A.W. Pharmacology of descending control systems. Phil. Trans. R. Soc. Lond. B 1985, 308:375-391.
90. Eaton M.J., Blits B., Ruitenberg M.J., Verhaagen J., Oudega M. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther. 2002, 9:1387-1395.
91. Edwards R.R., Fillingim R.B., Ness T.J. Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults. Pain 2003, 101:155-165.
92. Ennis M., Behbehani M., Shipley M.T., Van Bockstaele E.J., Aston-Jones G. Projections from the periaqueductal gray to the rostromedial pericoerulear region and nucleus locus coeruleus: anatomic and physiologic studies. J. Comp. Neurol. 1991, 306:480-494.
93. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science 1992, 258:1952-1955.
94. Fairbanks C.A., Stone L.S., Kitto K.F., Nguyen H.O., Posthumus I.J., Wilcox G.L. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J. Pharmacol. Exp. Ther. 2002, 300:282-290.
95. Fardin V., Oliveras J.L., Besson J.M. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. II. Differential characteristics of the analgesia induced by ventral and dorsal PAG stimulation. Brain Res. 1984, 306:125-139.
96. Fardin V., Oliveras J.L., Besson J.M. Projections from the periaqueductal gray matter to the B3 cellular area (nucleus raphe magnus and nucleus reticularis paragigantocellularis) as revealed by the retrograde transport of horseradish peroxidase in the rat. J. Comp. Neurol. 1984, 223:483-500.
97. Fields H.L. Sources of variability in the sensation of pain. Pain 1988, 33:195-200.
98. Fields H.L., Anderson S.D. Evidence that raphe-spinal neurons mediate opiate and midbrain stimulation-produced analgesias. Pain 1978, 5:333-349.
99. Fields H.L., Basbaum A.I. Brainstem control of spinal pain-transmission neurons. Annu. Rev. Physiol. 1978, 40:217-248.
100. Fields H.L., Basbaum A.I. Central Nervous System Mechanisms of Pain Modulation. Textbook of Pain 1999, 309-329. Churchill Livingstone, London. P.D. Wall, R. Melzack R (Eds.).
101. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 1991, 14:219-245.
102. Fields H.L., Bry J., Hentall I., Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J. Neurosci. 1983, 3:2545-2552.
103. Fields H.L., Malick A., Burstein R. Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J. Neurophysiol. 1995, 74:1742-1759.
104. Fields H.L., Vanegas H., Hentall I.D., Zorman G. Evidence that disinhibition of brain stem neurones contributes to morphine analgesia. Nature 1983, 306:684-686.
105. Finley J.C., Lindstrom P., Petrusz P. Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 1981, 33:28-42.
106. Flores J.A., El Banoua F., Galan-Rodriguez B., Fernandez-Espejo E. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain 2004, 110:205-214.
107. Fowler C.J., Fraser G.L. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem. Int. 1994, 24:401-426.
108. Frank L., Wiegand S.J., Siuciak J.A., Lindsay R.M., Rudge J.S. Effects of BDNF infusion on the regulation of TrkB protein and message in adult rat brain. Exp. Neurol. 1997, 145:62-70.
109. Friedrich A.E., Gebhart G.F. Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla. Pain 2003, 104:93-101.
110. Fritschy J.M., Grzanna R. Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn. J. Comp. Neurol. 1990, 291:553-582.
111. Fu J.J., Tang J.S., Yuan B., Jia H. Response of neurons in the thalamic nucleus submedius (Sm) to noxious stimulation and electrophysiological identification of on- and off-cells in rats. Pain 2002, 99:243-251.
112. Galeotti N., Malmberg-Aiello P., Bartolini A., Schunack W., Ghelardini C. H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. Neuropharmacology 2004, 47:295-303.
113. Gao K., Mason P. Serotonergic Raphe magnus cells that respond to noxious tail heat are not ON or OFF cells. J. Neurophysiol. 2000, 84:1719-1725.
114. Gao K., Kim Y.H., Mason P. SEROTONERGIC pontomedullary neurons are not activated by antinociceptive stimulation in the periaqueductal gray. J. Neurosci. 1997, 17:3285-3292.
115. Gao Y.J., Ren W.H., Zhang Y.Q., Zhao Z.Q. Contributions of the anterior cingulate cortex and amygdala to pain- and fear-conditioned place avoidance in rats. Pain 2004, 110:343-353.
116. Gauriau C., Bernard J.F. Pain pathways and parabrachial circuits in the rat. Exp. Physiol. 2002, 87:251-258.
117. Gaveriaux-Ruff C., Kieffer B.L. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 2002, 36:62-71.
118. Gebhart G.F. Opiate and opioid peptide effects on brain stem neurons: relevance to nociception and antinociceptive mechanisms. Pain 1982, 12:93-140.
119. Gebhart G.F. Descending Inhibition of Nociceptive Transmission. Basic Mechanisms of Headache 1988, 202-212. Elsevier. J. Olesen, L. Edvinsson (Eds.).
120. Gebhart G.F. Descending modulation of pain. Neurosci. Biobehav. Rev. 2004, 27:729-737.
121. Gebhart G.F., Sandkuhler J., Thalhammer J.G., Zimmermann M. Inhibition of spinal nociceptive information by stimulation in midbrain of the cat is blocked by lidocaine microinjected in nucleus raphe magnus and medullary reticular formation. J. Neurophysiol. 1983, 50:1446-1459.
122. Giesler G.J., Gerhart K.D., Yezierski R.P., Wilcox T.K., Willis W.D. Postsynaptic inhibition of primate spinothalamic neurons by stimulation in nucleus raphe magnus. Brain Res. 1981, 204:184-188.
123. Girardot M.N., Brennan T.J., Martindale M.E., Foreman R.D. Effects of stimulating the subcoeruleus-parabrachial region on the non-noxious and noxious responses of T1-T5 spinothalamic tract neurons in the primate. Brain Res. 1987, 409:19-30.
124. Gogas K.R., Presley R.W., Levine J.D., Basbaum A.I. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-fos expression. Neuroscience 1991, 42:617-628.
125. Gogas K.R., Cho H.J., Botchkina G.I., Levine J.D., Basbaum A.I. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain 1996, 65:9-15.
126. Goldstein A., Tachibana S., Lowney L.I., Hunkapiller M., Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:6666-6670.
127. Gozariu M., Bouhassira D., Willer J.C., Le Bars D. The influence of temporal summation on a C-fibre reflex in the rat: effects of lesions in the rostral ventromedial medulla (RVM). Brain Res. 1998, 792:168-172.
128. Graff-Guerrero A., Gonzalez-Olvera J., Fresan A., Gomez-Martin D., Carlos Mendez-Nunez J., Pellicer F. Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain. Brain Res. Cogn. Brain Res. 2005, May 31; (Epub ahead of print).
129. Grudt T.J., van den Pol A.N., Perl E.R. Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat. J. Physiol. 2002, 538(Pt 2):517-525.
130. Guan J.L., Wang Q.P., Shioda S. Immunoelectron microscopic examination of orexin-like immunoreactive fibers in the dorsal horn of the rat spinal cord. Brain Res. 2003, 987:86-92.
131. Guan Y., Terayama R., Dubner R., Ren K. Plasticity in excitatory amino acid receptor-mediated descending pain modulation after inflammation. J. Pharmacol. Exp. Ther. 2002, 300:513-520.
132. Guan Y., Guo W., Zou S.-P., Dubner R., Ren K. Inflammation-induced upregulation of AMPA receptor subunit expression in brain stem pain modulatory circuitry. Pain 2003, 104:401-413.
133. Guo W., Robbins M.T., Wei F., Zou S., Dubner R., Ren K. Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. J. Neurosci. 2006, 26:126-137.
134. Haber L.H., Martin R.F., Chung J.M., Willis W.D. Inhibition and excitation of primate spinothalamic tract neurons by stimulation in region of nucleus reticularis gigantocellularis. J. Neurophysiol. 1980, 43:1578-1593.
135. Hack S.P., Bagley E.E., Chieng B.C., Christie M.J. Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J. Neurosci. 2005, 25:3192-3198.
136. Hagbarth K.E., Kerr D.I. Central influences on spinal afferent conduction. J. Neurophysiol. 1954, 17:295-307.
137. Hammond D.L., Levy R.A., Proudfit H.K. Hypoalgesia following microinjection of noradrenergic antagonists in the nucleus raphe magnus. Pain 1980, 9:85-101.
138. Hammond D.L., Nelson V., Thomas D.A. Intrathecal methysergide antagonizes the antinociception, but not the hyperalgesia produced by microinjection of baclofen in the ventromedial medulla of the rat. Neurosci. Lett. 1998, 244:93-96.
139. Han J.S. Cholecystokinin octapeptide (CCK-8): a negative feedback control mechanism for opioid analgesia. Prog. Brain Res. 1995, 105:263-271.
140. Han J.S. Acupuncture and endorphins. Neurosci. Lett. 2004, 361:258-261.
141. Haws C.M., Williamson A.M., Fields H.L. Putative nociceptive modulatory neurons in the dorsolateral pontomesencephalic reticular formation. Brain Res. 1989, 483:272-282.
142. Hayes R.L., Bennett G.J., Newlon P.G., Mayer D.J. Behavioral and physiological studies of non-narcotic analgesia in the rat elicited by certain environmental stimuli. Brain Res. 1978, 155:69-90.
143. Hedo G., Lopez-Garcia J.A. Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in vitro. Neuropharmacology 2001, 41:862-869.
144. Heinricher M.M. Nociceptin/orphanin FQ: pain, stress and neural circuits. Life Sci. 2005, 77:3127-3132.
145. Heinricher M.M., Cheng Z.F., Fields H.L. Evidence for two classes of nociceptive modulating neurons in the periaqueductal gray. J. Neurosci. 1987, 7:271-278.
146. Heinricher M.M., Martenson M.E., Neubert M.J. Prostaglandin E2 in the midbrain periaqueductal gray produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla. Pain 2004, 110:419-426.
147. Heinricher M.M., McGaraughty S., Farr D.A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 1999, 81:57-65.
148. Heinricher M.M., McGaraughty S., Tortorici V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J. Neurophysiol. 2001, 85:280-286.
149. Heinricher M.M., Neubert M.J. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J. Neurophysiol. 2004, 92:1982-1989.
150. Heinricher M.M., Neubert M.J., Martenson M.E., Goncalves L. Prostaglandin E2 in the medial preoptic area produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla. Neuroscience 2004, 128:389-398.
151. Helmstetter F.J., Tershner S.A. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J. Neurosci. 1994, 14:7099-7108.
152. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand--nociceptin/orphanin FQ. Trends Pharmacol. Sci. 1997, 18:293-300.
153. Hernandez N., Vanegas H. Encoding of noxious stimulus intensity by putative pain modulating neurons in the rostral ventromedial medulla and by simultaneously recorded nociceptive neurons in the spinal dorsal horn of rats. Pain 2001, 91:307-315.
154. Hernandez N., Lopez Y., Vanegas H. Medullary on- and off-cell responses precede both segmental and thalamic responses to tail heating. Pain 1989, 39:221-230.
155. Hernandez-Peon R., Hagbarth K.E. Interaction between afferent and cortically induced reticular responses. J. Neurophysiol. 1955, 18:44-55.
156. Herrero J.F., Cervero F. Supraspinal influences on the facilitation of rat nociceptive reflexes induced by carrageenan monoarthritis. Neurosci. Lett. 1996, 209:21-24.
157. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature 2005, 435:1108-1112.
158. Holden J.E., Naleway E. Microinjection of carbachol in the lateral hypothalamus produces opposing actions on nociception mediated by alpha(1)- and alpha(2)-adrenoceptors. Brain Res. 2001, 911:27-36.
159. Holden J.E., Schwartz E.J., Proudfit H.K. Microinjection of morphine in the A7 catecholamine cell group produces opposing effects on nociception that are mediated by alpha1- and alpha2-adrenoceptors. Neuroscience 1999, 91:979-990.
160. Holden J.E., Van Poppel A.Y., Thomas S. Antinociception from lateral hypothalamic stimulation may be mediated by NK(1) receptors in the A7 catecholamine cell group in rat. Brain Res. 2002, 953:195-204.
161. Hough L.B., Nalwalk J.W., Li B.Y., Leurs R., Menge W.M., Timmerman H., Carlile M.E., Cioffi C., Wentland M. Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivatives. J. Pharmacol. Exp. Ther. 1997, 283:1534-1543.
162. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 1994, 46:157-203.
163. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975, 258:577-580.
164. Hung K.C., Wu H.E., Mizoguchi H., Leitermann R., Tseng L.F. Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. J. Pharmacol. Sci. 2003, 93:299-306.
165. Hunter J.C., Fontana D.J., Hedley L.R., Jasper J.R., Lewis R., Link R.E., Secchi R., Sutton J., Eglen R.M. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br. J. Pharmacol. 1997, 122:1339-1344.
166. Hurley R.W., Hammond D.L. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J. Neurosci. 2000, 20:1249-1259.
167. Hurley R.W., Hammond D.L. Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury. J. Neurosci. 2001, 21:2536-2545.
168. Hylden J.L.K., Anton F., Nahin R.L. Spinal lamina I projection neurons
169. Hylden J.L.K., Hayashi H., Dubner R., Bennett G.J. Physiology and morphology of the lamina I spinomesencephalic projection. J. Comp. Neurol. 1986, 247:505-515.
170. Hylden J.L.K., Thomas D.A., Iadarola M.J., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 1991, 194:135-143.
171. Ikeda K., Ide S., Han W., Hayashida M., Uhl G.R., Sora I. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol. Sci. 2005, 26:311-317.
172. Iwamoto E.T. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus. J. Pharmacol. Exp. Ther. 1991, 257:120-133.
173. Iwata K., Fukuoka T., Kondo E., Tsuboi Y., Tashiro A., Noguchi K., Masuda Y., Morimoto T., Kanda K. Plastic changes in nociceptive transmission of the rat spinal cord with advancing age. J. Neurophysiol. 2002, 87:1086-1093.
174. Janfaza D.R., Michna E., Pisini J.V., Ross E.L. Bedside implantation of a trial spinal cord stimulator for intractable anginal pain. Anesth. Analg. 1998, 87:1242-1244.
175. Janss A.J., Gebhart G.F. Spinal monoaminergic receptors mediate the antinociception produced by glutamate in the medullary lateral reticular nucleus. J. Neurosci. 1987, 7:2862-2873.
176. Janss A.J., Gebhart G.F. Quantitative characterization and spinal pathway mediating inhibition of spinal nociceptive transmission from the lateral reticular nucleus in the rat. J. Neurophysiol. 1988, 59:226-247.
177. Jasmin L., Rabkin S.D., Granato A., Boudah A., Ohara P.T. Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 2003, 424:316-320.
178. Jensen T.S., Gabhart G.F. General anatomy of antinociceptive systems. Basic mechanisms of headache 1988, 189-200. Elsevier. J. Olesen, L. Edvinsson L (Eds.).
179. Jensen T.S., Yaksh T.L. Brainstem excitatory amino acid receptors in nociception: microinjection mapping and pharmacological characterization of glutamate-sensitive sites in the brainstem associated with algogenic behavior. Neuroscience 1992, 46:535-547.
180. Jones S.L. Descending noradrenergic influences on pain. Prog. Brain Res. 1991, 88:381-394.
181. Jones S.L., Light A.R. Electrical stimulation in the medullary nucleus raphe magnus inhibits noxious heat-evoked fos protein-like immunoreactivity in the rat lumbar spinal cord. Brain Res. 1990, 530:335-338.
182. Jones S.L., Gebhart G.F. Quantitative characterization of ceruleospinal inhibition of nociceptive transmission in the rat. J. Neurophysiol. 1986, 56:1397-1410.
183. Jones S.L., Light A.R. Serotoninergic medullary raphespinal projection to the lumbar spinal cord in the rat: a retrograde immunohistochemical study. J. Comp. Neurol. 1992, 322:599-610.
184. Jones B.E., Pare M., Beaudet A. Retrograde labeling of neurons in the brain stem following injections of [3H]choline into the rat spinal cord. Neuroscience 1986, 18:901-916.
185. Kamibayashi T., Maze M. Clinical uses of alpha2 -adrenergic agonists. Anesthesiology 2000, 93:1345-1349.
186. Kauppila T., Kontinen V.K., Pertovaara A. Influence of spinalilzation on spinal withdrawal reflex responses varies depending on the submodality of the test stimulus and the experimental pathophysiological condition in the rat. Brain Res. 1998, 797:234-242.
187. Kayser V., Chen Y.L., Guilbaud G. Behavioural evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in carragenin-induced hyperalgesic rats. Brain Res. 1991, 560:237-244.
188. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:12048-12052.
189. Kim S.J., Calejesan A.A., Zhuo M. Activation of brainstem metabotropic glutamate receptors inhibits spinal nociception in adult rats. Pharmacol. Biochem. Behav. 2002, 73:429-437.
190. King M.A., Bradshaw S., Chang A.H., Pintar J.E., Pasternak G.W. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. J. Neurosci. 2001, 21:7788-7792.
191. Kingery W.S., Guo T.Z., Davies M.F., Limbird L., Maze M. The alpha(2A) adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice. Pain 2000, 85:345-358.
192. Kingery W.S., Agashe G.S., Guo T.Z., Sawamura S., Davies M.F., Clark J.D., Kobilka B.K., Maze M. Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology 2002, 96:367-374.
193. Kirchner A., Birklein F., Stefan H., Handwerker H.O. Left vagus nerve stimulation suppresses experimentally induced pain. Neurology 2000, 55:1167-1171.
194. Kivipelto L., Panula P. Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats. J. Comp. Neurol. 1991, 307:107-119.
195. Kovelowski C.J., Ossipov M.H., Sun H., Lai J., Malan T.P., Porreca F. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain 2000, 87:265-273.
196. Krout K.E., Jansen A.S., Loewy A.D. Periaqueductal gray matter projection to the parabrachial nucleus in rat. J. Comp. Neurol. 1998, 401:437-454.
197. Kumar K., Toth C., Nath R.K. Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery. 1997, 40:736-746. Discussion 746-747.
198. Lahdesmaki J., Scheinin M., Pertovaara A., Mansikka H. The alpha2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception. Eur. J. Pharmacol. 2003, 468:183-189.
199. Lakhlani P.P., MacMillan L.B., Guo T.Z., McCool B.A., Lovinger D.M., Maze M., Limbird L.E. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9950-9955.
200. LaMotte C.C. Lamina X of primate spinal cord: distribution of five neuropeptides and serotonin. Neuroscience 1988, 25:639-658.
201. Lavezzi A.M., Ottaviani G., Rossi L., Matturri L. Cytoarchitectural organization of the parabrachial/Kolliker-Fuse complex in man. Brain Dev. 2004, 26:316-320.
202. Le Bars D., Dickenson A.H., Besson J.M. Microinjection of morphine within nucleus raphe magnus and dorsal horn neurone activities related to nociception in the rat. Brain Res. 1980, 189:467-481.
203. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 1979, 6:283-304.
204. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain 1979, 6:305-327.
205. Lee H.S., Mihailoff G.A. Fluorescent double-label study of lateral reticular nucleus projections to the spinal cord and periaqueductal gray in the rat. Anat. Rec. 1999, 256:91-98.
206. Leiphart J.W., Dills C.V., Levy R.M. Decreased spinal alpha2a- and alpha2c-adrenergic receptor subtype mRNA in a rat model of neuropathic pain. Neurosci. Lett. 2003, 349:5-8.
207. Leung C.G., Mason P. Physiological properties of raphe magnus neurons during sleep and waking. J. Neurophysiol. 1999, 81:584-595.
208. Levine J.D., Gordon N.C., Fields H.L. The mechanism of placebo analgesia. Lancet. 1978, 2:654-657.
209. Li C.H., Chung D. Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:1145-1148.
210. Li Y.Q., Takada M., Matsuzaki S., Shinonaga Y., Mizuno N. Identification of periaqueductal gray and dorsal raphe nucleus neurons projecting to both the trigeminal sensory complex and forebrain structures: a fluorescent retrograde double-labeling study in the rat. Brain Res. 1993, 623:267-277.
211. Li P., Zhuo M. Silent glutamatergic synapses and nociception in mammalian spinal cord. Nature 1998, 393:695-698.
212. Lieberman M.D., Jarcho J.M., Berman S., Naliboff B.D., Suyenobu B.Y., Mandelkern M., Mayer E.A. The neural correlates of placebo effects: a disruption account. Neuroimage 2004, 22:447-455.
213. Light A.R., Casale E.J., Menetrey D.M. The effects of focal stimulation in nucleus raphe magnus and periaqueductal gray on intracellularly recorded neurons in spinal laminae I and II. J. Neurophysiol 1986, 56:555-571.
214. Lim G., Sung B., Ji R.R., Mao J. Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats. Pain 2003, 105:275-283.
215. Lima D., Almeida A. The medullary dorsal reticular nucleus as a pronociceptive centre of the pain control system. Prog. Neurobiol. 2002, 66:81-108.
216. Lin Q., Wu J., Peng Y.B., Cui M., Willis W.D. Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is modulated by guanosine 3′,5′-cyclic monophosphate. J. Neurophysiol. 1999, 81:1095-1103.
217. Liu R.H., Fung S.J., Reddy V.K., Barnes C.D. Localization of glutamatergic neurons in the dorsolateral pontine tegmentum projecting to the spinal cord of the cat with a proposed role of glutamate on lumbar motoneuron activity. Neuroscience 1995, 64:193-208.
218. Lu Y., Sweitzer S.M., Laurito C.E., Yeomans D.C. Differential opioid inhibition of C- and A delta- fiber mediated thermonociception after stimulation of the nucleus raphe magnus. Anesth. Analg. 2004, 98:414-419.
219. Ma F., Xie H., Dong Z.Q., Wang Y.Q., Wu G.C. Effects of electroacupuncture on orphanin FQ immunoreactivity and preproorphanin FQ mRNA in nucleus of raphe magnus in the neuropathic pain rats. Brain Res. Bull. 2004, 63:509-513.
220. Ma W., Eisenach J.C. Chronic constriction injury of sciatic nerve induces the up-regulation of descending inhibitory noradrenergic innervation to the lumbar dorsal horn of mice. Brain Res. 2003, 970:110-118.
221. Maione S., Marabese I., Leyva J., Palazzo E., de Novellis V., Rossi F. Characterisation of mGluRs which modulate nociception in the PAG of the mouse. Neuropharmacology 1998, 37:1475-1483.
222. Maione S., Marabese I., Oliva P., de Novellis V., Stella L., Rossi F., Filippelli A., Rossi F. Periaqueductal gray matter glutamate and GABA decrease following subcutaneous formalin injection in rat. Neuroreport 1999, 10:1403-1407.
223. Malick A., Strassman A.M., Burstein R. Trigeminohypothalamic and reticulohypothalamic tract neurons in the upper cervical spinal cord and caudal medulla of the rat. J. Neurophysiol. 2000, 84:2078-2112.
224. Malmberg A.B., Hedley L.R., Jasper J.R., Hunter J.C., Basbaum A.I. Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine. Br. J. Pharmacol. 2001, 132:1827-1836.
225. Malmberg-Aiello P., Lamberti C., Ghelardini C., Giotti A., Bartolini A. Role of histamine in rodent antinociception. Br. J. Pharmacol. 1994, 111:1269-1279.
226. Mansikka H., Pertovaara A. Supraspinal influence on hindlimb withdrawal thresholds and mustard oil-induced secondary allodynia in rats. Brain Res. Bull. 1997, 42:359-365.
227. Mansikka H., Lahdesmaki J., Scheinin M., Pertovaara A. Alpha(2A) adrenoceptors contribute to feedback inhibition of capsaicin-induced hyperalgesia. Anesthesiology 2004, 101:185-190.
228. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18:22-29.
229. Mantyh P.W. Connections of midbrain periaqueductal gray in the monkey. II. Descending efferent projections. J. Neurophysiol. 1983, 49:582-594.
230. Mantyh P.W., Peschanski M. Spinal projections from the periaqueductal grey and dorsal raphe in the rat, cat and monkey. Neuroscience 1982, 7:2769-2776.
231. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 2002, 100:213-217.
232. Mao J., Mayer D.J., Price D.D. Patterns of increased brain activity indicative of pain in a rat model of peripheral mononeuropathy. J. Neurosci. 1993, 13:2689-2702.
233. Marinelli S., Vaughan C.W., Schnell S.A., Wessendorf M.W., Christie M.J. Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J. Neurosci. 2002, 22:10847-10855.
234. Martin R.F., Haber L.H., Willis W.D. Primary afferent depolarization of identified cutaneous fibers following stimulation in medial brain stem. J. Neurophysiol. 1979, 42:779-790.
235. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976, 197:517-532.
236. Mason P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu. Rev. Neurosci. 2001, 24:737-777.
237. Matsutani K., Tsuruoka M., Shinya A., Furuya R., Kawawa T., Inoue T. Coeruleotrigeminal suppression of nociceptive sensorimotor function during inflammation in the craniofacial region of the rat. Brain Res. Bull. 2003, 61:73-80.
238. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996, 383:819-823.
239. Mayer D.J., Liebeskind J.C. Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioral analysis. Brain Res. 1974, 68:73-93.
240. Mayer D.J., Wolfle T.L., Akil H., Carder B., Liebeskind J.C. Analgesia from electrical stimulation in the brainstem of the rat. Science 1971, 174:1351-1354.
241. McMahon S.B., Wall P.D. Descending excitation and inhibition of spinal cord lamina I projection neurons. J. Neurophysiol. 1988, 59:1204-1219.
242. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science 1965, 150:971-979.
243. Menetrey D., Chaouch A., Binder D., Besson J.M. The origin of the spinomesencephalic tract in the rat: an anatomical study using the retrograde transport of horseradish peroxidase. J. Comp. Neurol. 1982, 206:193-207.
244. Meng F., Xie G.X., Thompson R.C., Mansour A., Goldstein A., Watson S.J., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:9954-9958.
245. Meng I.D., Manning B.H., Martin W.J., Fields H.L. An analgesia circuit activated by cannabinoids. Nature 1998, 395:381-383.
246. Meng X.W., Budra B., Skinner K., Ohara P.T., Fields H.L. Noradrenergic input to nociceptive modulatory neurons in the rat rostral ventromedial medulla. J. Comp. Neurol. 1997, 377:381-391.
247. Meyerson B.A., Linderoth B. Mechanisms of spinal cord stimulation in neuropathic pain. Neurol. Res. 2000, 22:285-292.
248. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 1997, 340:1-15.
249. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
250. Miki K., Zhou Q.Q., Guo W., Guan Y., Terayama R., Dubner R., Ren K. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J. Neurophysiol. 2002, 87:750-760.
251. Miki K., Iwata K., Tsuboi Y., Morimoto T., Kondo E., Dai Y., Ren K., Noguchi K. Dorsal column-thalamic pathway is involved in thalamic hyperexcitability following peripheral nerve injury: a lesion study in rats with experimental mononeuropathy. Pain 2000, 85:263-271.
252. Millan M.J. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
253. Mobarakeh J.I., Takahashi K., Sakurada S., Nishino S., Watanabe H., Kato M., Yanai K. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides 2005, 26:767-777.
254. Mokha S.S., McMillan J.A., Iggo A. Pathways mediating descending control of spinal nociceptive transmission from the nuclei locus coeruleus (LC) and raphe magnus (NRM) in the cat. Exp. Brain Res. 1986, 61:597-606.
255. Mollereau C., Roumy M., Zajac J.M. Opioid-modulating peptides: mechanisms of action. Curr. Top Med Chem. 2005, 5:341-355.
256. Montagne-Clavel J., Oliveras J.L. Are ventromedial medulla neuronal properties modified by chronic peripheral inflammation? A single-unit study in the awake, freely moving polyarthritic rat. Brain Res. 1994, 657:92-104.
257. Morgan M.M., Gold M.S., Liebeskind J.C., Stein C. Periaqueductal gray stimulation produces a spinally mediated, opioid antinociception for the inflamed hindpaw of the rat. Brain Res. 1991, 545:17-23.
258. Morinville A., Cahill C.M., Esdaile M.J., Aibak H., Collier B., Kieffer B.L., Beaudet A. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J. Neurosci. 2003, 23:4888-4898.
259. Murphy A.Z., Ennis M., Rizvi T.A., Behbehani M.M., Shipley M.T. Fos expression induced by changes in arterial pressure is localized in distinct, longitudinally organized columns of neurons in the rat midbrain periaqueductal gray. J. Comp. Neurol. 1995, 360:286-300.
260. Nalwalk J.W., Svokos K., Taraschenko O., Leurs R., Timmerman H., Hough L.B. Activation of brain stem nuclei by improgan, a non-opioid analgesic. Brain Res. 2004, 1021:248-255.
261. Neil A., Kayser V., Gacel G., Besson J.-M., Guilbaud G. Opioid receptor types and antinociceptive activity in chronic inflammation: both kappa and mu opiate agonistic effects are enhanced in arthritic rats. Eur. J. Pharmacol. 1986, 130:203-208.
262. Ness T.J., Fillingim R.B., Randich A., Backensto E.M., Faught E. Low intensity vagal nerve stimulation lowers human thermal pain thresholds. Pain 2000, 86:81-85.
263. Neubert J.K., Widmer C.G., Malphurs W., Rossi H.L., Vierck C.J., Caudle R.M. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005, 116:386-395.
264. North R.A., Yoshimura M. The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro. J. Physiol. 1984, 349:43-55.
265. Nuseir K., Proudfit H.K. Bidirectional modulation of nociception by GABA neurons in the dorsolateral pontine tegmentum that tonically inhibit spinally projecting noradrenergic A7 neurons. Neuroscience 2000, 96:773-783.
266. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 1998, 392:286-289.
267. Olave M.J., Maxwell D.J. Neurokinin-1 projection cells in the rat dorsal horn receive synaptic contacts from axons that possess alpha2C-adrenergic receptors. J. Neurosci. 2003, 23:6837-6846.
268. Oliveras J.L., Besson J.M. Stimulation-produced analgesia in animals: behavioural investigations. Prog. Brain Res. 1988, 77:141-157.
269. Oliveras J.L., Redjemi F., Guilbaud G., Besson J.M. Analgesia induced by electrical stimulation of the inferior centralis nucleus of the raphe in the cat. Pain 1975, 1:139-145.
270. Omote K., Kawamata T., Kawamata M., Namiki A. Formalin-induced nociception activates a monoaminergic descending inhibitory system. Brain Res. 1998, 814:194-198.
271. Ossipov M.H., Kovelowski C.J., Porreca F. The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective delta-opioid antagonist. Neurosci. Lett. 1995, 184:173-176.
272. Ossipov M.H., Lai J., Malan T.P., Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann. N. Y. Acad. Sci. U. S. A. 2000, 909:12-24.
273. Ossipov M.H., Lai J., King T., Vanderah T.W., Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers. 2005, 80:319-324.
274. Ozdogan U.K., Lahdesmaki J., Mansikka H., Scheinin M. Loss of amitriptyline analgesia in alpha 2A-adrenoceptor deficient mice. Eur. J. Pharmacol. 2004, 485:193-196.
275. Pan L., Xu J., Yu R., Xu M.M., Pan Y.X., Pasternak G.W. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene. Oprm. Neuroscience 2005, 133:209-220.
276. Pan Z.Z., Hirakawa N., Fields H.L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 2000, 26:515-522.
277. Pan Z.Z., Tershner S.A., Fields H.L. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature 1997, 389:382-385.
278. Pan Z.Z., Williams J.T., Osborne P.B. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J. Physiol. 1990, 427:519-532.
279. Pasternak G.W. Incomplete cross tolerance and multiple mu opioid peptide receptors. Trends Pharmacol. Sci. 2001, 22:67-70.
280. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Academic Press. 5th edn.
281. Peng Y.B., Lin Q., Willis W.D. Involvement of alpha-2 adrenoceptors in the periaqueductal gray-induced inhibition of dorsal horn cell activity in rats. J. Pharmacol. Exp. Ther. 1996, 278:125-135.
282. Pert C.B., Snyder S.H. Opiate receptor: demonstration in nervous tissue. Science 1973, 179:1011-1014.
283. Pertovaara A., Keski-Vakkuri U., Kalmari J., Wei H., Panula P. Response properties of neurons in the rostroventromedial medulla of neuropathic rats: attempted modulation of responses by [1DMe]NPYF, a neuropeptide FF analogue. Neuroscience 2001, 105:457-468.
284. Pertovaara A., Wei H., Hamalainen M.M. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci. Lett. 1996, 218:127-130.
285. Petrovic P., Carlsson K., Petersson K.M., Hansson P., Ingvar M. Context-dependent deactivation of the amygdala during pain. J. Cogn. Neurosci. 2004, 16:1289-1301.
286. Porreca F., Ossipov M.H., Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002, 25:319-325.
287. Porreca F., Burgess S.E., Gardell L.R., Vanderah T.W., Malan T.P., Ossipov M.H., Lappi D.A., Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the micro-opioid receptor. J. Neurosci. 2001, 21:5281-5288.
288. Price D.D. Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol. Interv. 2002, 2:392-403.
289. Proudfit H.K. The challenge of defining brainstem pain modulation circuits. J. Pain 2002, 3:350-354.
290. Randich A., Gebhart G.F. Vagal afferent modulation of nociception. Brain Res. Rev 1992, 17:77-99.
291. Randich A., Maixner W. Interactions between cardiovascular and pain regulatory systems. Neurosci. Biobehav. Rev. 1984, 8:343-367.
292. Reddy S.V., Maderdrut J.L., Yaksh T.L. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J. Pharmacol. Exp. Ther. 1980, 213:525-533.
293. Reichling D.B., Basbaum A.I. Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: II. Electron microscopic immunocytochemical evidence of GABAergic control over the projection from the periaqueductal gray to the nucleus raphe magnus in the rat. J. Comp. Neurol. 1990, 302:378-393.
294. Reinert A., Treede R., Bromm B. The pain inhibiting pain effect: an electrophysiological study in humans. Brain Res. 2000, 862:103-110.
295. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
296. Ren K. The medulla oblongata: the vital center for descending modulation. J. Pain 2002, 3:355-357.
297. Ren K., Ruda M.A. Descending modulation of Fos expression after persistent peripheral inflammation. Neuroreport 1996, 7:2186-2190.
298. Ren K., Dubner R. Enhanced descending modulation of nociception in rats with persistent hindpaw inflammation. J. Neurophysiol. 1996, 76:3025-3037.
299. Ren K., Dubner R. Descending modulation in presistent pain: an update. Pain 2002, 100:1-6.
300. Ren K., Randich A., Gebhart G.F. Modulation of spinal nociceptive transmission from nuclei tractus solitarii: a relay for effects of vagal afferent stimulation. J. Neurophysiol. 1990, 63:971-986.
301. Ren K., Randich A., Gebhart G.F. Spinal serotonergic and kappa opioid receptors mediate facilitation of the tail flick reflex produced by vagal afferent stimulation. Pain 1991, 45:321-329.
302. Ren K., Zhuo M., Willis W.D. Multiplicity and Plasticity of Descending Modulation of Nociception: Implications for Persistent Pain 2000, 387-400. IASP Press. M. Devor, M.C. Rowbotham, Z. Wiesenfeld-Hallin (Eds.).
303. Renno W.M., Beitz A.J. Peripheral inflammation is associated with decreased veratridine-induced release of GABA in the rat ventrocaudal periaqueductal gray: microdialysis study. J. Neurol. Sci. 1999, 163:105-110.
304. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969, 164:444-445.
305. Richter R.C., Behbehani M.M. Evidence for glutamic acid as a possible neurotransmitter between the mesencephalic nucleus cuneiformis and the medullary nucleus raphe magnus in the lightly anesthetized rat. Brain Res. 1991, 544:279-286.
306. Rivot J.P., Chaouch A., Besson J.M. Nucleus raphe magnus modulation of response of rat dorsal horn neurons to unmyelinated fiber inputs: partial involvement of serotonergic pathways. J. Neurophysiol. 1980, 44:1039-1057.
307. Rivot J.P., Chiang C.Y., Besson J.M. Increase of serotonin metabolism within the dorsal horn of the spinal cord during nucleus raphe magnus stimulation, as revealed by in vivo electrochemical detection. Brain Res. 1982, 238:117-126.
308. Rizvi T.A., Ennis M., Behbehani M.M., Shipley M.T. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J. Comp. Neurol. 1991, 303:121-131.
309. Rossi G.C., Mathis J.P., Pasternak G.W. Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ141-157 in mice. Neuroreport 1998, 9:1165-1168.
310. Ruda M.A. Opiates and pain pathways: demonstration of enkephalin synapses on dorsal horn projection neurons. Science 1982, 215:1523-1525.
311. Ruda M.A. Spinal dorsal horn circuitry involved in the brain stem control of nociception. Prog. Brain Res. 1988, 77:129-140.
312. Ruda M.A., Coffield J., Steinbusch H.W. Immunocytochemical analysis of serotonergic axons in laminae I and II of the lumbar spinal cord of the cat. J. Neurosci. 1982, 2:1660-1671.
313. Sagen J., Proudfit H.K. Effect of intrathecally administered noradrenergic antagonists on nociception in the rat. Brain Res. 1984, 310:295-301.
314. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
315. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
316. Sandkuhler J. The organization and function of endogenous antinociceptive systems. Prog. Neurobiol. 1996, 50:49-81.
317. Sawamura S., Kingery W.S., Davies M.F., Agashe G.S., Clark J.D., Kobilka B.K., Hashimoto T., Maze M. Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors. J. Neurosci. 2000, 20:9242-9251.
318. Sawynok J. The 1988 Merck Frosst Award. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies. Can. J. Physiol. Pharmacol. 1989, 67:975-988.
319. Schaible H.G., Neugebauer V., Cervero F., Schmidt R.F. Changes in tonic descending inhibition of spinal neurons with articular input during the development of acute arthritis in the cat. J. Neurophysiol. 1991, 66:1021-1032.
320. Schechtmann G., Wallin J., Meyerson B.A., Linderoth B. Intrathecal clonidine potentiates suppression of tactile hypersensitivity by spinal cord stimulation in a model of neuropathy. Anesth. Analg. 2004, 99:135-139.
321. Schnell C., Ulucan C., Ellrich J. Atypical on-, off- and neutral cells in the rostral ventromedial medulla oblongata in rat. Exp. Brain Res. 2002, 145:64-75.
322. Sessle B.J., Hu J.W., Dubner R., Lucier G.E. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effect of naloxone. J. Neurophysiol. 1981, 45:193-207.
323. Shealy C.N. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. J. Altern. Complement. Med. 2003, 9:619-623.
324. Shealy C.N., Mortimer J.T., Reswick J.B. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth. Analg. 1967, 46:489-491.
325. Simkin P.P., O'hara M. Nonpharmacologic relief of pain during labor: systematic reviews of five methods. Am. J. Obstet. Gynecol. 2002, 186:S131-S159.
326. Simon E.J., Hiller J.M., Edelman I. Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. U. S. A. 1973, 70:1947-1949.
327. Siuciak J.A., Wong V., Pearsall D., Wiegand S.J., Lindsay R.M. BDNF produces analgesia in the formalin test and modifies neuropeptide levels in rat brain and spinal cord areas associated with nociception. Eur. J. Neurosci. 1995, 7:663-670.
328. Skinner K., Basbaum A.I., Fields H.L. Cholecystokinin and enkephalin in brain stem pain modulating circuits. Neuroreport 1997, 8:2995-2998.
329. Skirboll L., Hokfelt T., Dockray G., Rehfeld J., Brownstein M., Cuello A.C. Evidence for periaqueductal cholecystokinin-substance P neurons projecting to the spinal cord. J. Neurosci. 1983, 3:1151-1157.
330. Sluka K.A., Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J. Pain 2003, 4:109-121.
331. Sluka K.A., Westlund K.N. Spinal projections of the locus coeruleus and the nucleus subcoeruleus in the Harlan and the Sasco Sprague-Dawley rat. Brain Res. 1992, 579:67-73.
332. Sonohata M., Furue H., Katafuchi T., Yasaka T., Doi A., Kumamoto E., Yoshimura M. Actions of noradrenaline on substantia gelatinosa neurones in the rat spinal cord revealed by in vivo patch recording. J. Physiol. 2004, 555(Pt 2):515-526.
333. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1544-1549.
334. Sorkin L.S., McAdoo D.J., Willis W.D. Raphe magnus stimulation-induced antinociception in the cat is associated with release of amino acids as well as serotonin in the lumbar dorsal horn. Brain Res. 1993, 618:95-108.
335. Sotgui M.L. Descending influence on dorsal horn neuronal hyperactivity in a rat model of neuropathic pain. Neuroreport. 1993, 4:21-24.
336. Sounvoravong S., Nakashima M.N., Wada M., Nakashima K. Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain. Eur. J. Pharmacol. 2004, 484:217-223.
337. Spinella M., Cooper M.L., Bodnar R.J. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain 1996, 64:545-552.
338. Stamford J.A. Descending control of pain. Br. J. Anaesth. 1995, 75:217-227.
339. Stevens R.T., Hodge C.J., Apkarian A.V. Kolliker-Fuse nucleus: the principal source of pontine catecholaminergic cells projecting to the lumbar spinal cord of cat. Brain Res. 1982, 239:589-594.
340. Stiller C.O., Gustafsson H., Fried K., Brodin E. Opioid-induced release of neurotensin in the periaqueductal gray matter of freely moving rats. Brain Res. 1997, 774:149-158.
341. Stone L.S., MacMillan L.B., Kitto K.F., Limbird L.E., Wilcox G.L. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J. Neurosci. 1997, 17:7157-7165.
342. Stone L.S., Vulchanova L., Riedl M.S., Wang J., Williams F.G., Wilcox G.L., Elde R. Effects of peripheral nerve injury on alpha-2A and alpha-2C adrenergic receptor immunoreactivity in the rat spinal cord. Neuroscience 1999, 93:1399-1407.
343. Sugiyo S., Takemura M., Dubner R., Ren K. Trigeminal transition zone-rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats. J. Comp. Neurol. (in press). 2005.
344. Suzuki R., Rahman W., Hunt S.P., Dickenson A.H. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn
345. Suzuki R., Rygh L.J., Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol. Sci. 2004, 25:613-617.
346. Suzuki R., Green G.M., Millan M.J., Dickenson A.H. Electrophysiologic characterization of the antinociceptive actions of S18616, a novel and potent alpha 2-adrenoceptor agonist, after acute and persistent pain states. J. Pain 2002, 3:234-243.
347. Suzuki R., Morcuende S., Webber M., Hunt S.P., Dickenson A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat. Neurosci. 2002, 5:1319-1326.
348. Swanson L.W., Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 1975, 163:467-505.
349. Tanaka M., Matsumoto Y., Murakami T., Hisa Y., Ibata Y. The origins of catecholaminergic innervation in the rostral ventromedial medulla oblongata of the rat. Neurosci. Lett. 1996, 207:53-56.
350. Tang J., Ko S., Ding H.K., Qiu C.S., Calejesan A.A., Zhuo M. Pavlovian fear memory induced by activation in the anterior cingulate cortex. Mol. Pain 2005, 1:6.
351. Tavares I., Lima D. The caudal ventrolateral medulla as an important inhibitory modulator of pain transmission at the spinal cord. J. Pain 2002, 3:337-346.
352. Terayama R., Guan Y., Dubner R., Ren K. Activity-induced plasticity in brain stem pain modulatory circuitry after inflammation. Neuroreport 2000, 11:1915-1919.
353. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. (Copenh). 1973, 32:317-320.
354. Tattersall J.E., Cervero F., Lumb B.M. Effects of reversible spinalization on the visceral input to viscerosomatic neurons in the lower thoracic spinal cord of the cat. J. Neurophysiol. 1986, 56:785-796.
355. Thomas D.A., McGowan M.K., Hammond D.L. Microinjection of baclofen in the ventromedial medulla of rats: antinociception at low doses and hyperalgesia at high doses. J Pharmacol. Exp. Ther. 1995, 275:274-284.
356. Thurston C.L., Randich A. Responses of on and off cells in the rostral ventral medulla to stimulation of vagal afferents and changes in mean arterial blood pressure in intact and cardiopulmonary deafferented rats. Pain 1995, 62:19-38.
357. Tjolsen A., Berge O.G., Hole K. Lesions of bulbo-spinal serotonergic or noradrenergic pathways reduce nociception as measured by the formalin test. Acta Physiol. Scand. 1991, 142:229-236.
358. Todd A.J., Millar J. Antagonism of 5-hydroxytryptamine-evoked excitation in the superficial dorsal horn of the cat spinal cord by methysergide. Neurosci Lett. 1984, 48:167-170.
359. Tseng L.F., Tang R. Different mechanisms mediate beta-endorphin- and morphine-induced inhibition of the tail-flick response in rats. J. Pharmacol. Exp. Ther. 1990, 252:546-551.
360. Tsou K., Jang C.S. Studies on the site of analgesic action of morphine by intracerebral microinjections. Sci. Sin. 1964, 13:1099-1109.
361. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
362. Tsuruoka M., Willis W.D. Bilateral lesions in the area of the nucleus locus coeruleus affect the development of hyperalgesia during carrageenan-induced inflammation. Brain Res. 1996, 726:233-236.
363. Tsuruoka M., Hitoto T., Hiruma Y., Matsui Y. Neurochemical evidence for inflammation-induced activation of the coeruleospinal modulation system in the rat. Brain Res. 1999, 821:236-240.
364. Tsuruoka M., Arai Y.C., Nomura H., Matsutani K., Willis W.D. Unilateral hindpaw inflammation induces bilateral activation of the locus coeruleus and the nucleus subcoeruleus in the rat. Brain Res. Bull. 2003, 61:117-123.
365. Urban M.O., Gebhart G.F. Characterization of biphasic modulation of spinal nociceptive transmission by neurotensin in the rat rostral ventromedial medulla. J. Neurophysiol. 1997, 78:1550-1562.
366. Urban M.O., Gebhart G.F. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999, 96:7687-7692.
367. Urban M.O., Jiang M.C., Gebhart G.F. Participation of central descending nociceptive facilitatory system in secondary hyperalgesia produced by mustard oil. Brain Res. 1996, 737:83-91.
368. Urban M.O., Hama A.T., Bradbury M., Anderson J., Varney M.A., Bristow L. Role of metabotropic glutamate receptor subtype 5 (mGluR5) in the maintenance of cold hypersensitivity following a peripheral mononeuropathy in the rat. Neuropharmacology 2003, 44:983-993.
369. Valverde O., Ledent C., Beslot F., Parmentier M., Roques B.P. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Eur. J. Neurosci. 2000, 12:533-539.
370. Van Bockstaele E.J., Aston-Jones G., Pieribone V.A., Ennis M., Shipley M.T. Subregions of the periaqueductal gray topographically innervate the rostral ventral medulla in the rat. J. Comp. Neurol. 1991, 309:305-327.
371. Van den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 1999, 19:3171-3182.
372. Van den Pol A.N., Collins W.F. Paraventriculospinal tract as a model for axon injury: spinal cord. J. Comp. Neurol. 1994, 349:244-258.
373. Vanegas H., Schaible H.-G. Descending control of persistent pain: inhibitory or facilitatory?. Brain Res. Rev. 2004, 46:295-309.
374. Vanegas H., Barbaro N.M., Fields H.L. Midbrain stimulation inhibits tail-flick only at currents sufficient to excite rostral medullary neurons. Brain Res. 1984, 321:127-133.
375. van Praag H., Frenk H. The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes. Brain Res. 1990, 524:101-105.
376. Vaughan C.W., Connor M., Jennings E.A., Marinelli S., Allen R.G., Christie M.J. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. J. Physiol. 2001, 534(Pt 3):849-859.
377. Veraksits A., Runkorg K., Kurrikoff K., Raud S., Abramov U., Matsui T., Bourin M., Koks S., Vasar E. Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors. Psychopharmacology (Berl). 2003, 166:168-175.
378. Vierck C.J., Kline R., Wiley R.G. Comparison of operant escape and innate reflex responses to nociceptive skin temperatures produced by heat and cold stimulation of rats. Behav. Neurosci. 2004, 118:627-635.
379. Walker J.M., Huang S.M. Endocannabinoids in pain modulation. Prostaglandins Leukot. Essent. Fatty Acids. 2002, 66:235-242.
380. Wall P.D. The laminar organization of dorsal horn and effects of descending impulses. J. Physiol. 1967, 188:403-423.
381. Wallace B.A., Ashkan K., Benabid A.L. Deep brain stimulation for the treatment of chronic, intractable pain. Neurosurg. Clin. N. Am. 2004, 15:343-357. vii.
382. Wang H., Wessendorf M.W. Mu- and delta-opioid receptor mRNAs are expressed in spinally projecting serotonergic and nonserotonergic neurons of the rostral ventromedial medulla. J. Comp. Neurol. 1999, 404:183-196.
383. Wang H., Wessendorf M.W. Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla. Neuroscience 2002, 109:619-634.
384. Wang Q., Mao L.M., Shi Y.S., Han J.S. Lumbar intrathecal administration of naloxone antagonizes analgesia produced by electrical stimulation of the hypothalamic arcuate nucleus in pentobarbital-anesthetized rats. Neuropharmacology 1990, 29:1123-1129.
385. Watanabe S., Kuwaki T., Yanagisawa M., Fukuda Y., Shimoyama M. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport 2005, 16:5-8.
386. Watkins L.R., Mayer D.J. Organization of endogenous opiate and nonopiate pain control systems. Science 1982, 216:1185-1192.
387. Watkins L.R., Milligan E.D., Maier S.F. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol. 2003, 521:1-21.
388. Wei F., Dubner R., Ren K. Nucleus reticularis gigantocellularis and nucleus raphe magnus in the brain stem exert opposite effects on behavioral hyperalgesia and spinal Fos protein expression after peripheral inflammation. Pain 1999, 80:127-141.
389. Westlund K.N., Bowker R.M., Ziegler M.G., Coulter J.D. Noradrenergic projections to the spinal cord of the rat. Brain Res. 1983, 263:15-31.
390. Westlund K.N., Carlton S.M., Zhang D., Willis W.D. Direct catecholaminergic innervation of primate spinothalamic tract neurons. J. Comp. Neurol. 1990, 299:178-186.
391. Wiertelak E.P., Roemer B., Maier S.F., Watkins L.R. Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res. 1997, 748:143-150.
392. Willer J.C., Boureau F., Albe-Fessard D. Supraspinal influences on nociceptive flexion reflex and pain sensation in man. Brain Res. 1979, 179:61-68.
393. Williams F.G., Beitz A.J. Chronic pain increases brainstem proneurotensin/neuromedin-N mRNA expression: a hybridization-histochemical and immunohistochemical study using three different rat models for chronic nociception. Brain Res. 1993, 611:87-102.
394. Willis W.D., Westlund K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol. 1997, 14:2-31.
395. Willis W.D., Westlund K.N., Carlton S.M. Pain. The Rat Nervous System 1995, 725-750. Academic Press. 2nd edn. G. Paxinos (Ed.).
396. Xie J.Y., Herman D.S., Stiller C.O., Gardell L.R., Ossipov M.H., Lai J., Porreca F., Vanderah T.W. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J. Neurosci. 2005, 25:409-416.
397. Yaksh T.L. Opiate receptors for behavioral analgesia resemble those related to the depression of spinal nociceptive neurons. Science 1978, 199:1231-1233.
398. Yaksh T.L. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res. 1979, 160:180-185.
399. Yaksh T.L., Tyce G.M. Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cord. Brain Res. 1979 1979, 171:176-181.
400. Yamamoto T., Saito O., Shono K., Hirasawa S. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. Eur. J. Pharmacol. 2003, 481:175-180.
401. Yamamoto T., Nozaki-Taguchi N., Sakashita Y., Kimura S. Nociceptin/orphanin FQ: role in nociceptive information processing. Prog. Neurobiol. 1999, 57:527-535.
402. Yang H.Y., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:7757-7761.
403. Yoshida A., Chen K., Moritani M., Yabuta N.H., Nagase Y., Takemura M., Shigenaga Y. Organization of the descending projections from the parabrachial nucleus to the trigeminal sensory nuclear complex and spinal dorsal horn in the rat. J. Comp. Neurol. 1997, 383:94-111.
404. Young R.F., Tronnier V., Rinaldi P.C. Chronic stimulation of the Kolliker-Fuse nucleus region for relief of intractable pain in humans. J. Neurosurg. 1992, 76:979-985.
405. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997, 386:499-502.
406. Zagon A. Internal connections in the rostral ventromedial medulla of the rat. J. Auton. Nerv. Syst. 1995, 53:43-56.
407. Zagon A., Meng X., Fields H.L. Intrinsic membrane characteristics distinguish two subsets of nociceptive modulatory neurons in rat RVM. J. Neurophysiol. 1997, 78:2848-2858.
408. Zaki P.A., Bilsky E.J., Vanderah T.W., Lai J., Evans C.J., Porreca F. Opioid receptor types and subtypes: the delta receptor as a model. Annu. Rev. Pharmacol. Toxicol. 1996, 36:379-401.
409. Zambreanu L., Wise R.G., Brooks J.C., Iannetti G.D., Tracey I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain 2005, 114:397-407.
410. Zeilhofer H.U. The glycinergic control of spinal pain processing. Cell. Mol. Life Sci. 2005, 2005 Jun 17 (Epub ahead of print).
411. Zeitz K.P., Guy N., Malmberg A.B., Dirajlal S., Martin W.J., Sun L., Bonhaus D.W., Stucky C.L., Julius D., Basbaum A.I. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J. Neurosci. 2002, 22:1010-1019.
412. Zhang D.X., Owens C.M., Willis W.D. Two forms of inhibition of spinothalamic tract neurons produced by stimulation of the periaqueductal gray and the cerebral cortex. J. Neurophysiol. 1991, 65:1567-1579.
413. Zhang Y., Yang Z., Gao X., Wu G. The role of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats. Pain 2001, 92:201-211.
414. Zhang J., Hoffert C., Vu H.K., Groblewski T., Ahmad S., O'Donnell D. Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci. 2003, 17:2750-2754.
415. Zhang R.X., Lao L., Wang L., Liu B., Wang X., Ren K., Berman B.M. Involvement of opioid receptors in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation. Brain Res. 2004, 1020:12-17.
416. Zhong F.X., Ji X.Q., Tsou K. Intrathecal DSP4 selectively depletes spinal noradrenaline and attenuates morphine analgesia. Eur. J. Pharmacol. 1985, 116:327-330.
417. Zhuo M., Gebhart G.F. Spinal cholinergic and monoaminergic receptors mediate descending inhibition from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 1990, 535:67-78.
418. Zhuo M., Gebhart G.F. Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 1991, 550:35-48.
419. Zhuo M., Gebhart G.F. Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and pars alpha in the rat. J. Neurophysiol. 1992, 67:1599-1614.
420. Zhuo M., Gebhart G.F. Biphasic modulation of spinal nociceptive transmission from the medullary raphe nuclei in the rat. J. Neurophysiol. 1997, 78:746-758.
421. Zorman G., Belcher G., Adams J.E., Fields H.L. Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat. Brain Res. 1982, 236:77-84.
422. Calejesan A.A., Ch'ang M.H., Zhuo M. Spinal serotonergic receptors mediate facilitation of a nociceptive reflex by subcutaneous formalin injection into the hindpaw in rats. Brain Res. 1998, 798:46-54.
423. Dubner R., Ren K. Endogenous mechanisms of sensory modulation. Pain Suppl. 1999, 6:S45-S53.
424. Guan Y., Guo W., Robbins M.T., Dubner R., Ren K. Changes in AMPA receptor phosphorylation in the rostral ventromedial medulla after inflammatory hyperalgesia. Neurosci. Lett. 2004, 366:201-205.
425. Janss A.J., Cox B.F., Brody M.J., Gebhart G.F. Dissociation of antinociceptive from cardiovascular effects of stimulation in the lateral reticular nucleus in the rat. Brain Res. 1987, 405:140-149.
426. Jasmin L., Boudah A., Ohara P.T. Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception. J. Comp. Neurol. 2003, 460:38-55.
427. Mason P. Central mechanisms of pain modulation. Curr. Op. Neurobiol. 1997, 9:436-441.
428. Rahman W., Suzuki R., Rygh L.J., Dickenson A.H. Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation. Neurosci. Lett. 2004, 361:229-231.
429. Vaccarino A.L., Chorney D.A. Descending modulation of central neural plasticity in the formalin pain test. Brain Res. 1994, 666:104-108.
430. Villanueva L., Desbois C., Le Bars D., Bernard J.F. Organization of diencephalic projections from the medullary subnucleus reticularis dorsalis and the adjacent cuneate nucleus: a retrograde and anterograde tracer study in the rat. J. Comp. Neurol. 1998, 390:133-160.
431. Wei F., Ren K., Dubner R. Inflammation-induced Fos protein expression in the rat spinal cord is enhanced following dorsolateral or ventrolateral funiculus lesions. Brain Res. 1998, 782:136-141.
432. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1768.